• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年 4 月至 7 月,田纳西州 SARS-CoV-2 病毒症状与病毒培养阳性结果的关联。

Association of Symptoms and Viral Culture Positivity for SARS-CoV-2-Tennessee, April-July 2020.

机构信息

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

出版信息

Influenza Other Respir Viruses. 2024 Jun;18(6):e13318. doi: 10.1111/irv.13318.

DOI:10.1111/irv.13318
PMID:39031815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11190945/
Abstract

BACKGROUND

Understanding how symptoms are associated with SARS-CoV-2 culture positivity is important for isolation and transmission control guidelines.

METHODS

Individuals acutely infected with SARS-CoV-2 in Tennessee and their household contacts were recruited into a prospective study. All participants self-collected nasal swabs daily for 14 days and completed symptom diaries from the day of illness onset through day 14 postenrollment. Nasal specimens were tested for SARS-CoV-2 using RT-qPCR. Positive specimens with cycle threshold values < 40 were sent to the Centers for Disease Control and Prevention (CDC) for viral culture. First, we modeled the association between symptoms and the risk of culture positivity using an age-adjusted generalized additive model (GAM) accounting for repeated measurements within participants and a symptom-day spline. Next, we investigated how timing of symptom resolution was associated with the timing of culture resolution.

RESULTS

In a GAM restricted to follow-up days after symptoms began, the odds of a specimen being culture positive was significantly increased on days when wheezing, loss of taste or smell, runny nose, nasal congestion, sore throat, fever, or any symptom were reported. For all symptoms except sore throat, it was more common for participants to have culture resolution before symptom resolution than for culture to resolve after or on the same day as symptom resolution.

CONCLUSIONS

Overall, symptomatic individuals were more likely to be SARS-CoV-2 viral culture positive. For most symptoms, culture positivity was more likely to end before symptoms resolved. However, a proportion of individuals remained culture positive after symptom resolved, across all symptoms.

摘要

背景

了解症状与 SARS-CoV-2 培养阳性之间的关联对于隔离和传播控制指南很重要。

方法

田纳西州急性感染 SARS-CoV-2 的个体及其家庭接触者被招募到一项前瞻性研究中。所有参与者每天自我采集鼻拭子,共采集 14 天,并在发病当天至第 14 天入组后完成症状日记。使用 RT-qPCR 检测鼻拭子中的 SARS-CoV-2。循环阈值<40 的阳性标本被送往疾病预防控制中心(CDC)进行病毒培养。首先,我们使用年龄调整广义加性模型(GAM)对症状与培养阳性风险之间的关联进行建模,该模型考虑了参与者内部的重复测量和症状日样条。接下来,我们调查了症状消退的时间与培养消退的时间之间的关系。

结果

在仅针对症状开始后随访日的 GAM 中,出现喘息、味觉或嗅觉丧失、流涕、鼻塞、喉咙痛、发热或任何症状的那天,标本培养阳性的可能性显著增加。除了喉咙痛,对于大多数症状,培养结果在症状消退之前得到解决的情况比培养结果在症状消退之后或同一天得到解决的情况更为常见。

结论

总体而言,有症状的个体更有可能成为 SARS-CoV-2 病毒培养阳性。对于大多数症状,培养阳性更有可能在症状消退之前结束。然而,在所有症状中,仍有一部分人在症状消退后仍保持培养阳性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b601/11190945/e1743605e785/IRV-18-e13318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b601/11190945/0ce5f7e39a4f/IRV-18-e13318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b601/11190945/e1743605e785/IRV-18-e13318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b601/11190945/0ce5f7e39a4f/IRV-18-e13318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b601/11190945/e1743605e785/IRV-18-e13318-g001.jpg

相似文献

1
Association of Symptoms and Viral Culture Positivity for SARS-CoV-2-Tennessee, April-July 2020.2020 年 4 月至 7 月,田纳西州 SARS-CoV-2 病毒症状与病毒培养阳性结果的关联。
Influenza Other Respir Viruses. 2024 Jun;18(6):e13318. doi: 10.1111/irv.13318.
2
Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020.2020 年 4 月至 9 月,田纳西州和威斯康星州家庭中 SARS-CoV-2 感染的传播。
MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1631-1634. doi: 10.15585/mmwr.mm6944e1.
3
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study.SARS-CoV-2 人体挑战后病毒向空气中和环境中的排放:一项 1 期、开放标签、首次人体研究。
Lancet Microbe. 2023 Aug;4(8):e579-e590. doi: 10.1016/S2666-5247(23)00101-5. Epub 2023 Jun 9.
4
COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.检测时的 COVID-19 症状与 SARS-CoV-2 检测门诊患者的阳性率之间的关系。
PLoS One. 2021 Dec 10;16(12):e0260879. doi: 10.1371/journal.pone.0260879. eCollection 2021.
5
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.2020 - 2021年南非农村和城市地区严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的发病率、传播及再感染情况:PHIRST-C队列研究结果
Lancet Infect Dis. 2022 Jun;22(6):821-834. doi: 10.1016/S1473-3099(22)00069-X. Epub 2022 Mar 14.
6
SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.2020 - 2021年南非农村和城市地区严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的发病率、传播及再感染情况:PHIRST-C队列研究结果
medRxiv. 2021 Dec 4:2021.07.20.21260855. doi: 10.1101/2021.07.20.21260855.
7
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.接种加强针后感染 SARS-CoV-2:一项前瞻性、基于社区的病例对照研究中的疾病和症状特征。
J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28.
8
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
9
Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.德国巴伐利亚州 COVID-19 患者的呼吸道样本中 SARS-CoV-2 的检测和病毒 RNA 脱落与症状发作的关系。
Epidemiol Infect. 2021 Jun 23;149:e150. doi: 10.1017/S0950268821001345.
10
SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.SARS-CoV-2 病毒脱落和快速抗原检测性能 - 呼吸道病毒传播网络,2022 年 11 月至 2023 年 5 月。
MMWR Morb Mortal Wkly Rep. 2024 Apr 25;73(16):365-371. doi: 10.15585/mmwr.mm7316a2.

本文引用的文献

1
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022.2020-2022 年加利福尼亚州和田纳西州可培养病毒检测与 SARS-CoV-2 家庭传播的关联。
J Infect Dis. 2023 Jun 15;227(12):1343-1347. doi: 10.1093/infdis/jiad018.
2
Surveillance and Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA, Antigen, Virus Isolation, and Self-Reported Symptoms in a Longitudinal Study With Daily Sampling.在一项每日采样的纵向研究中,对严重急性呼吸综合征冠状病毒 2 病毒 RNA、抗原、病毒分离和自我报告症状进行监测和关联。
Clin Infect Dis. 2022 Nov 14;75(10):1698-1705. doi: 10.1093/cid/ciac282.
3
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
4
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.2020 - 2021年南非农村和城市地区严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的发病率、传播及再感染情况:PHIRST-C队列研究结果
Lancet Infect Dis. 2022 Jun;22(6):821-834. doi: 10.1016/S1473-3099(22)00069-X. Epub 2022 Mar 14.
5
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.SARS-CoV-2 G614 感染(武汉株)患者新冠病毒载量随症状出现和严重程度的变化轨迹。
JAMA Netw Open. 2022 Jan 4;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796.
6
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel.美国疾病控制与预防中心2019新型冠状病毒(2019-nCoV)实时逆转录聚合酶链反应诊断试剂首批产品分析。
PLoS One. 2021 Dec 15;16(12):e0260487. doi: 10.1371/journal.pone.0260487. eCollection 2021.
7
Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020.2020 年 4 月至 9 月,田纳西州和威斯康星州家庭中 SARS-CoV-2 感染的传播。
MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1631-1634. doi: 10.15585/mmwr.mm6944e1.
8
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.症状持续时间和多州医疗保健系统网络中 COVID-19 门诊患者恢复健康延迟的风险因素 - 美国,2020 年 3 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. doi: 10.15585/mmwr.mm6930e1.
9
Development and validation of the Influenza Intensity and Impact Questionnaire (FluiiQ™).《流感严重程度和影响问卷(FluiiQ™)》的制定与验证。
Value Health. 2011 Jul-Aug;14(5):687-99. doi: 10.1016/j.jval.2010.12.005. Epub 2011 May 8.